T2 Biosystems to be delisted from Nasdaq - Investing.com
2025-02-11 • Google News
T2 Biosystems Inc (TTOO)
US$ 0.5799-18.52%
Price Chart
Key Statistics
Market Cap
$ 2.19M
P/E Ratio
0.00
Revenue (TTM)
$ 7.68M
Volume
1.52M
52W High
$ 5.40
52W Low
$ 0.06
Dividend Yield
0.00%
Beta
0.45
Technicals
50-Day MA
0.1471
200-Day MA
0.4231
52 Week High
5.4
52 Week Low
0.056
About TTOO
T2 Biosystems, Inc., an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally.
Employees
113
Headquarters
Lexington, MA
CEO
Mr. Craig R. Jalbert CIRA
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg